Treprostinil: Comprehensive Guide for PAH Treatment & Dosage

Summary of Key Points

Treprostinil is a medication used to manage serious lung and heart conditions, including pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It works by relaxing the blood vessels in the lungs, improving circulation, and reducing the strain on the heart. Treprostinil is available in several forms, such as injections, inhalations, and oral tablets. Always consult your healthcare provider before starting or adjusting your dosage.

Names of Medication

US Brand Names: Remodulin, Tyvaso, Orenitram (Treprostinil)

The generic name refers to the official medical name of the active ingredient in a medication. It is listed in parentheses after the brand name.

Pharmacologic Category

Prostacyclin Analog

Vasodilator

Treprostinil Dosage

Treprostinil is prescribed for various conditions, and the dosage will depend on the specific condition being treated. Always follow your doctor’s instructions and consult them before making any changes to your dose. You can also schedule a telemedicine appointment with one of our providers for personalized guidance.

Pulmonary Arterial Hypertension (PAH) Treatment

Oral (Orenitram): Start with 0.25 mg two or three times daily. The dose may be increased by 0.25 mg every 3-4 days based on tolerance.

Inhalation (Tyvaso): Start with 18 mcg (3 breaths) four times daily. The dose may be increased to a maximum of 54 mcg (9 breaths) four times daily.

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Heart Failure

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Eisenmenger Syndrome

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Scleroderma

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Idiopathic Pulmonary Fibrosis

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Congenital Heart Disease

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Left Heart Disease

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

COPD (Chronic Obstructive Pulmonary Disease)

Inhalation (Tyvaso): Start with 18 mcg (3 breaths) four times daily. The dose may be increased to a maximum of 54 mcg (9 breaths) four times daily.

Pulmonary Veno-Occlusive Disease

Subcutaneous/Intravenous (Remodulin): Start with 1.25 ng/kg/min, with gradual increases based on tolerance.

Dosage Forms and Strengths

Oral Tablets (Orenitram): 0.125 mg, 0.25 mg, 1 mg, 2.5 mg, 5 mg

Inhalation Solution (Tyvaso): 0.6 mg/mL

Injection (Remodulin): 1 mg/mL, 2.5 mg/mL, 5 mg/mL, 10 mg/mL

Administration Instructions for Treprostinil

Treprostinil can be administered in different ways depending on the prescribed form. Oral tablets should be taken with food to minimize stomach upset. Inhaled forms should be used with a nebulizer as directed by your healthcare provider. Injections are typically administered subcutaneously (under the skin) or intravenously (into a vein) by a healthcare professional or under their guidance.

Contraindications for Treprostinil

A contraindication is a specific situation where a medication should not be used because it may cause harm. It’s important to know if you have any conditions or are taking any medications that might make Treprostinil unsafe for you.

Treprostinil is contraindicated in the following situations:

1. Severe liver disease: Treprostinil is processed by the liver, and if your liver is not functioning properly, the medication may accumulate in your body, leading to potentially dangerous side effects.
2. Severe low blood pressure (hypotension): Treprostinil can further lower blood pressure, which may cause dizziness, fainting, or even shock in individuals who already have low blood pressure.
3. Allergic reactions to Treprostinil: If you have had an allergic reaction to Treprostinil or any of its components in the past, you should not take this medication, as it could trigger life-threatening reactions such as anaphylaxis.
4. Bleeding disorders or taking blood thinners: Treprostinil can increase the risk of bleeding, especially if you have a bleeding disorder or are taking medications like warfarin (Coumadin) that thin the blood.

Drug-to-Drug Interactions

Treprostinil can interact with other medications, which may increase the risk of side effects or reduce the effectiveness of either drug. It’s important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Some medications that interact with Treprostinil include:

1. Warfarin (Coumadin): Treprostinil may increase the risk of bleeding when taken with blood thinners like warfarin.
2. Diuretics (Lasix, furosemide): These medications can lower blood pressure, and when combined with Treprostinil, the risk of dangerously low blood pressure may increase.
3. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen (Advil, Motrin): Combining these drugs with Treprostinil may increase the risk of bleeding.
4. Antihypertensive medications (lisinopril, metoprolol): These medications lower blood pressure, and taking them with Treprostinil may cause your blood pressure to drop too low.

Treprostinil in Pregnancy

Is it safe to take Treprostinil during pregnancy?

The safety of Treprostinil during pregnancy has not been fully established. While animal studies suggest there may be some risk to the fetus, there are no well-controlled studies in pregnant women. If you are pregnant or planning to become pregnant, it is essential to discuss the potential risks and benefits of Treprostinil with your healthcare provider. They will help you carefully weigh the possible risks to your baby against the benefits of treating conditions such as pulmonary arterial hypertension.

Treprostinil While Breastfeeding

Is it safe to take Treprostinil while breastfeeding?

It is currently unclear whether Treprostinil passes into breast milk. Due to the potential for serious side effects in a nursing infant, it is generally recommended to avoid breastfeeding while taking Treprostinil. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to explore your treatment options. They may suggest alternative therapies or advise you to discontinue breastfeeding while using Treprostinil.

Estimated Cost of Treprostinil Medication

The cost of Treprostinil can vary depending on the form and dosage prescribed. Without insurance, a 30-day supply may range from $2,500 to $4,000. However, using a GoodRx coupon, the price may be reduced to around $2,000 for a 30-day supply. Be sure to check with your pharmacy for the most accurate pricing and inquire about any available discounts or patient assistance programs.

Possible Alternatives to Treprostinil

If Treprostinil is not suitable for you, there are alternative treatments and lifestyle modifications that may help manage your condition. Always consult your healthcare provider before making any changes to your treatment plan. If you need to speak with a provider, you can schedule a telemedicine appointment with one of our healthcare professionals at your convenience.

Alternative Treatments for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension (PAH): Alternatives include medications such as sildenafil (Revatio) or bosentan (Tracleer), as well as lifestyle changes like regular exercise and a low-sodium diet.

Alternative Treatments for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Chronic thromboembolic pulmonary hypertension (CTEPH): Surgical options, such as pulmonary thromboendarterectomy, or medications like riociguat (Adempas) may be considered.

Alternative Treatments for Heart Failure

Heart failure: Medications such as ACE inhibitors, beta-blockers, or diuretics may be alternatives. Lifestyle changes, including reducing salt intake and engaging in regular physical activity, can also be beneficial.

Alternative Treatments for Eisenmenger Syndrome

Eisenmenger syndrome: Treatment options may include oxygen therapy, medications like bosentan (Tracleer), or, in severe cases, heart-lung transplantation.

Alternative Treatments for Scleroderma

Scleroderma: Immunosuppressive drugs such as methotrexate or mycophenolate mofetil (CellCept) may be used. Physical therapy and skin care routines are also important components of treatment.

Alternative Treatments for Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic pulmonary fibrosis (IPF): Medications like pirfenidone (Esbriet) or nintedanib (Ofev) may help slow the progression of the disease.

Alternative Treatments for Congenital Heart Disease

Congenital heart disease: Depending on the specific type, treatment may involve surgery, medications, or lifestyle changes such as regular exercise and a heart-healthy diet.

Alternative Treatments for Left Heart Disease

Left heart disease: Medications like ACE inhibitors or beta-blockers, along with lifestyle changes such as reducing salt intake and managing stress, may be effective alternatives.

Alternative Treatments for COPD

COPD: Inhalers such as tiotropium (Spiriva) or lifestyle changes like quitting smoking and participating in pulmonary rehabilitation can help manage symptoms.

Alternative Treatments for Pulmonary Veno-Occlusive Disease (PVOD)

Pulmonary veno-occlusive disease (PVOD): Treatment options are limited, but in severe cases, lung transplantation may be considered.

Recent Updates on Treprostinil Research

Recent research on Treprostinil has focused on expanding its use in treating various forms of pulmonary hypertension. A 2021 study found that inhaled Treprostinil improved exercise capacity and reduced symptoms in patients with pulmonary hypertension due to interstitial lung disease, including idiopathic pulmonary fibrosis. Ongoing studies are also exploring the potential benefits of Treprostinil in treating heart failure and other conditions associated with elevated blood pressure in the lungs. These findings may lead to broader applications of Treprostinil in the future.

As research continues to evolve, staying informed about new developments is crucial. If you have any questions about how this research may impact your treatment, consider scheduling a telemedicine appointment with one of our healthcare providers today.

James Kingsley

Learn More